Stigmatization of People with Substance Dependency in Community Pharmacies
Research reveals that individuals with substance dependency often face stigma in community pharmacies, underscoring the need for compassionate, stigma-free healthcare services to support recovery.
Recent research highlights that individuals with substance dependency often experience stigma and discrimination when visiting community pharmacies. These negative attitudes from pharmacy staff include the use of derogatory language, segregation practices, and unwelcoming behaviors, which can impede their access to vital healthcare services. The study, conducted among pharmacy students and newly qualified pharmacists in Scotland, revealed inconsistent care: while some staff demonstrated compassion and professionalism, others fell short, potentially jeopardizing patients' recovery journeys.
Importantly, the research underscored that respectful treatment and empathy positively influence patient outcomes, encouraging a supportive environment conducive to recovery. Participants also emphasized the need to enhance pharmacy education, equipping future professionals to manage challenging interactions effectively.
The study monitored over 30,000 patients in Scotland receiving opioid agonist therapy—a treatment involving medications like methadone for opioid addiction—and noted that drug-related deaths in 2023 totaled 1,172. These findings align with ongoing efforts to destigmatize healthcare for individuals with substance dependency. Experts advocate for a shift toward holistic, non-judgmental care by pharmacists, who are increasingly seen as critical access points for health services within communities.
Adrian Mackenzie of Healthcare Improvement Scotland noted that reducing stigma can aid in harm reduction and foster a recovery-oriented system. The research also revealed societal issues, such as the misconception that individuals with substance dependency are beyond help or are morally responsible for their condition. Experts like Professor Andrew Radley stressed that community pharmacies are pivotal in supporting vulnerable populations and should serve as inclusive, caring environments.
This study, led by Dr. Natalie Weir from the University of Strathclyde, illustrates the importance of professionalism and empathy in pharmacy practice. It calls for enhanced training and awareness, ensuring that pharmacy teams provide equitable and dignified care to all patients, especially those battling addiction.
Source: https://medicalxpress.com/news/2025-09-people-substance-stigmatization-community-pharmacies.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative AI Tool Enhances Cancer Tissue Analysis for Better Diagnostics
Mount Sinai researchers have introduced MARQO, an AI-powered platform that significantly improves the accuracy and efficiency of cancer tissue analysis, paving the way for advancements in diagnosis and personalized treatment.
Remaining Evidence Gaps for AI-Powered Eye Imaging Devices in Clinical Use
A recent review highlights significant evidence gaps in AI-based eye imaging devices approved for clinical use, emphasizing the need for transparent validation and diverse population testing to ensure effective and equitable eye care.
Genetic Factors Influence Childhood Obesity Risk in Children Exposed to Gestational Diabetes
New research reveals that genetic variations in the GLP-1R gene may determine why some children exposed to gestational diabetes develop obesity while others do not. This discovery highlights the importance of genetics in childhood obesity risk and potential personalized medical interventions.
The Impact of Internet Bots on Scientific Research Integrity
The rise of sophisticated internet bots and AI technologies presents significant challenges to maintaining integrity in online scientific research, risking data validity and trust.